The industry is facing even bigger challenges when recruiting, retaining, and engaging patients due to COVID-19. This has delayed and de-prioritized many clinical trials across the globe. In response, IBM Watson Health has optimized IBM Clinical Development to enable decentralized trials for its clients, specifically leveraging COA capabilities and a unified, cloud-based CDMS platform that allows remote monitoring and study control. As a user of the platform, Biorasi will discuss how ICD is helping the CRO overcome COVID-19-related challenges and how to help Sponsors operate more efficiently.

https://vshow.on24.com/vshow/WatsonHealth2020/content/2427796

Clinical development

Webinar